65,437 trials
Atrial Fibrillation · Atrial Fibrillation New Onset
Primary: Percentage of Participants With Treatment Success at 12 Months After Antiarrhythmic Drug (AAD) Initiation or Ablation Utilizing the Arctic Front Advance™ Cardiac…
Post-surgical Pain
Primary: Change in Postsurgical Pain Based on the Weighted Sum of Pain Intensity (SPI) Assessments Over 96 Hours of the NRS Scores = Area Under the Curve (AUC) — 317.09; 321.72…
Coronary Artery Disease · Coronary Disease · Myocardial Ischemia
Primary: Number of Participants With Device Procedural Success — 187 Participants
Amyotrophic Lateral Sclerosis · Motor Neuron Disease · Neuromuscular Diseases
Primary: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) Slope Change — -1.66; -1.24 Change in ALSFRS-R Total Score Per Month — p=0.03
Dry Eye
Primary: Inferior Corneal Staining (ICS) Score — 1.8; 1.9 units on a scale
Facioscapulohumeral Muscular Dystrophy (FSHD)
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs) — 3; 6; 6; 5 Participants
Metabolism and Nutrition Disorder · Overweight or Obesity
Primary: Change in Body Weight (%) — -15.6; -2.8; -16.9; -3.1 Percentage point — p=<.0001
Young Adult, Cancer, Physical Activity
Primary: Self-efficacy for Physical Activity — 62.6; 56.2 score on a scale — p=0.22
Influenza, Human
Primary: Number of Participants With Flu Shot Receipt at or Before Appointment — 1113; 1210; 1150; 1163 Participants
Toxic Effect of Organophosphate and Carbamate Insecticides
Primary: Area Under the Curve to From Time Zero to Infinity (AUC_∞) — 286.396; 493.808; 816.465 min*ng/mL
Unilateral Hearing Loss
Primary: HEAR-QL 26 Questionnaire — 69.61; 74.05; 71.04; 80.21 score on a scale
Obesity · Overweight
Primary: Change in Body Weight (%) - Semaglutide 2.4 mg Versus Placebo — -9.9; -3.3; -10.7; -3.1 Percentage point of body weight — p=<0.0001
Tinnitus
Primary: Tinnitus Functional Index (TFI) - Measure of Tinnitus Distress — 54.04; 53.93; 29.44; 47.35 score on a scale
Pain
Primary: Peak Alpha Frequency (Hz) — 10.04 frequency (Hz)
COVID-19 · Sars-CoV2 · Pneumonia
Primary: Proportion of Subjects Alive and Off of Oxygen at Day 14 — 1; 1 Participants